Summary: The widespread use of bioprosthetic mesh in breast reconstruction has revealed an increased risk of seroma and infection, and a high financial cost. This study introduces a technique that mitigates these shortcomings using an autologous dermal graft (Autoderm). Indications, operative technique, and 1-year outcomes are reviewed. Thirty-six breasts in 21 patients underwent six unilateral and 15 bilateral, implant-based breast reconstructions with Autoderm. Mean follow-up was 365 days (range, 273 to 575 days). The overall complication rate was 13.9 percent. No patients developed breast cellulitis, hyperemia, periprosthetic infection, or seroma. There was one implant exposure following expansion. Autoderm provides the advantages of lower pole support and breast shaping, without the disadvantages of increased infection, seroma, and the high cost associated with allograft and xenograft meshes.
CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
From the Department of Plastic Surgery, University of Texas M. D. Anderson Cancer Center.
Received for publication October 15, 2012; accepted November 6, 2012.
Disclosure: Dr. Selber is a consultant for TEI Biosciences. Drs. Clemens, Oates, and Baumann have no financial conflicts of interest associated with this article.
Department of Plastic Surgery, University of Texas M. D. Anderson Cancer Center, 1400 Pressler, Unit 1488, Houston, Texas 77030, email@example.com